Alpha vs. gamma sarcoglycanopathy: DNA tests solve a case from Argentina

Area of Science:

• Neuromuscular Disorders
• Molecular Genetics
• Biochemistry

Background:

• Sarcoglycanopathies are a group of inherited muscular dystrophies caused by mutations in sarcoglycan genes.
• Immunohistochemistry is a key diagnostic tool, assessing the expression levels of different sarcoglycan proteins.
• Deficiency in gamma-sarcoglycan was suspected based on initial protein expression analysis.

Observation:

• Immunostaining showed normal alpha-, reduced beta- and delta-, and markedly reduced gamma-sarcoglycan.
• Despite the suspicion of gamma-sarcoglycanopathy, DNA analysis identified compound heterozygous pathogenic mutations in the alpha-sarcoglycan gene (SGCA).

Findings:

• Two novel pathogenic mutations, c.229C > T (p.Arg77Cys) and c.850C > T (p.Arg284Cys), were identified in the SGCA gene.
• These mutations were found in compound heterozygosity, indicating a complex genetic basis.
• Additional sequence variations were noted in other sarcoglycan genes (SGCB, SGCG, SGCD).

Implications:

• This case highlights the importance of integrating genetic findings with protein expression data for accurate sarcoglycanopathy diagnosis.
• The identified SGCA mutations may lead to a revised understanding of genotype-phenotype correlations in sarcoglycanopathies.
• Further research is needed to elucidate the functional impact of these mutations and their contribution to disease pathogenesis.